These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 6273308)

  • 1. Effect of ambient temperature on the cell-mediated immune response in mice immunized with herpes simplex virus.
    Choudhury S; Pal SR
    Indian J Exp Biol; 1981 Sep; 19(9):823-5. PubMed ID: 6273308
    [No Abstract]   [Full Text] [Related]  

  • 2. Migration inhibition test in mice inoculated with Herpes simplex virus.
    Koyama H; Kasahara S; Akiyama T
    Kitasato Arch Exp Med; 1974 Jun; 47(1-2):63-7. PubMed ID: 4375230
    [No Abstract]   [Full Text] [Related]  

  • 3. Mucosal application of plasmid-encoded IL-15 sustains a highly protective anti-Herpes simplex virus immunity.
    Toka FN; Rouse BT
    J Leukoc Biol; 2005 Jul; 78(1):178-86. PubMed ID: 15817700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-dependent cellular cytotoxicity against cells infected with herpes simplex virus type 1 in Igh-1 disparate congenic mice.
    Tamesis RR; Rodriguez A; Hoang-Xuan T; Foster CS
    Ger J Ophthalmol; 1993 Aug; 2(4-5):218-23. PubMed ID: 8220102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.
    Morrison LA; Knipe DM
    Virology; 1997 Dec; 239(2):315-26. PubMed ID: 9434723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes.
    Manickan E; Rouse RJ; Yu Z; Wire WS; Rouse BT
    J Immunol; 1995 Jul; 155(1):259-65. PubMed ID: 7602102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Split T-cell tolerance in herpes simplex virus-infected mice and its implication for anti-viral immunity.
    Nash AA; Ashford NP
    Immunology; 1982 Apr; 45(4):761-7. PubMed ID: 6279490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro production of immune interferon by spleen cells of mice immunized with herpes simplex virus.
    Kirchner H; Zawatzky R; Hirt HM
    Cell Immunol; 1978 Sep; 40(1):204-10. PubMed ID: 212209
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of DNA priming-protein boosting on enhancing humoral immunity and protecting mice against lethal HSV infections.
    Soleimanjahi H; Roostaee MH; Rasaee MJ; Mahboudi F; Kazemnejad A; Bamdad T; Zandi K
    FEMS Immunol Med Microbiol; 2006 Feb; 46(1):100-6. PubMed ID: 16420602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of tumor necrosis factor DNA on immune response to DNA immunization against herpes simplex virus].
    Klimova RR; Kozlov AIu; Shingarova LN; Nekrasova OV; Boldyreva EF; Guseva TS; Parshina OV; Malinovskaia VV; Novikov VV; Kushch AA
    Mol Biol (Mosk); 2004; 38(2):333-42. PubMed ID: 15125240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stress-induced effects on integral immune components involved in herpes simplex virus (HSV)-specific memory cytotoxic T lymphocyte activation.
    Bonneau RH
    Brain Behav Immun; 1996 Jun; 10(2):139-63. PubMed ID: 8811937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes simplex virus hepatitis and related problems.
    Dienes HP; Schirmacher P; Weise K; Falke D
    Int Rev Exp Pathol; 1994; 35():1-38. PubMed ID: 7860188
    [No Abstract]   [Full Text] [Related]  

  • 13. Similar immune response to nonlethal infection with herpes simplex virus-1 in sensitive (BALB/c) and resistant (C57BL/6) strains of mice.
    Brenner GJ; Cohen N; Moynihan JA
    Cell Immunol; 1994 Sep; 157(2):510-24. PubMed ID: 8069930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of a sub-unit vaccine using an animal model of herpes simplex keratitis.
    Harney BA; Easty DL; Skinner GR
    Trans Ophthalmol Soc U K (1962); 1983; 103 ( Pt 3)():342-6. PubMed ID: 6324419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune responses to DNA free herpes simplex proteins in man.
    Cappel R; Sprecher S; de Cuyper F
    Dev Biol Stand; 1982; 52():345-50. PubMed ID: 6299843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies to the distinct antigenic sites on glycoproteins C and B and their protective abilities in herpes simplex virus infection.
    Bystrická M; Petríková M; Zatovicová M; Soláriková L; Kostolanský F; Mucha V; Russ G
    Acta Virol; 1997 Feb; 41(1):5-12. PubMed ID: 9199708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity.
    Kohl S; Loo LS
    J Immunol; 1982 Jul; 129(1):370-6. PubMed ID: 6282968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Short-term therapeutic effect of an inactivated herpes simplex virus type 1 vaccine on herpes simplex keratitis].
    Zhang YQ
    Zhonghua Yan Ke Za Zhi; 1983 Nov; 19(6):339-42. PubMed ID: 6327206
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of stress on memory cytotoxic T lymphocyte-mediated protection against herpes simplex virus infection at mucosal sites.
    Wonnacott KM; Bonneau RH
    Brain Behav Immun; 2002 Apr; 16(2):104-17. PubMed ID: 11908921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of mucosal and systemic immunity by enteric administration of nonreplicating herpes simplex virus expressing cytokines.
    Kuklin NA; Daheshia M; Marconi PC; Krisky DM; Rouse RJ; Glorioso JC; Manican E; Rouse BT
    Virology; 1998 Jan; 240(2):245-53. PubMed ID: 9454698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.